iSiP Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $4.49M

  • Investors
  • 3

iSiP General Information

Description

Developer of artificial intelligence drug discovery technology intended for pharmaceutical research and development purposes. The company's platform integrates high-performance computing, physical simulation, and machine learning to generate novel small molecule hit compounds without the need for extensive training data or existing compound information, enabling the global healthcare sector to accelerate the identification of high-value drug candidates with greater efficiency and reduced costs.

Contact Information

Website
corp-isip.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 3 Shibuya, Shibuya-ward
  • Tokyo, Bunkyo-ku
  • Japan
Primary Industry
Discovery Tools (Healthcare)
Corporate Office
  • 3 Shibuya, Shibuya-ward
  • Tokyo, Bunkyo-ku
  • Japan

iSiP Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iSiP Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 22-May-2025 $4.49M Completed Generating Revenue
1. Seed Round 22-Aug-2023 Completed Generating Revenue
To view iSiP’s complete valuation and funding history, request access »

iSiP Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Class A Preferred
S Preferred
To view iSiP’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

iSiP Patents

iSiP Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026038558-A1 Gpr17 inhibitor and uses thereof Pending 14-Aug-2024

iSiP Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
DNX Ventures Venture Capital Minority
D3 (Tokyo) Venture Capital Minority
DEEPCORE Venture Capital Minority
To view iSiP’s complete investors history, request access »

iSiP FAQs

  • When was iSiP founded?

    iSiP was founded in 2022.

  • Where is iSiP headquartered?

    iSiP is headquartered in Tokyo, Japan.

  • What industry is iSiP in?

    iSiP’s primary industry is Discovery Tools (Healthcare).

  • Is iSiP a private or public company?

    iSiP is a Private company.

  • What is the current valuation of iSiP?

    The current valuation of iSiP is .

  • What is iSiP’s current revenue?

    The current revenue for iSiP is .

  • How much funding has iSiP raised over time?

    iSiP has raised $6.1M.

  • Who are iSiP’s investors?

    DNX Ventures, D3 (Tokyo), and DEEPCORE have invested in iSiP.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process